SMAD3 and myocardial infarction: Altered TGF-β signaling may mediate the opposing actions of Nur77 in CFs and cardiomyocytes since recently; it has been shown that SMAD3 signaling in cardiomyocytes and cardiac fibroblasts has different effects on cardiac remodeling post-MI.